India Globalization Capi... Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
India Globalization Capital Inc IGC AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.37 19:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 0.37 - 1.56
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.37 USD


Draw Mode:

India Globalization Capital Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 19.63M 53.07M 49.08M $ 397.00k $ - -0.30 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 15.00%

more financials information »

India Globalization Capi... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IGC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.41510.43380.370.3894014162,986-0.0451-10.86%
1 Month0.4210.45890.370.413648128,985-0.051-12.11%
3 Months0.54770.740.370.4654181311,855-0.1777-32.44%
6 Months0.450.84320.370.5885187493,320-0.08-17.78%
1 Year1.301.560.370.7721691473,874-0.93-71.54%
3 Years0.76084.650.2632.072,885,116-0.3908-51.37%
5 Years0.58514.580.2632.932,951,790-0.215-36.75%

India Globalization Capi... Description

India Globalization Capital Inc is an investment holding company. The company's operating segment includes Infrastructure and Life Sciences. It generates maximum revenue from the Life Sciences segment. The Infrastructure Business segment involves the execution of construction contracts, the rental of heavy construction equipment, and the purchase and resale of physical commodities used in infrastructure. The Life Sciences Segment includes biopharmaceuticals and Over the Counter Products Geographically, it derives a majority of revenue from Hong Kong and also has a presence in India.